CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Open-market sale 10% owner sold 2,764 shares at $8.51 ($23,522)
- 4 Open-market sale 10% owner sold 81,787 shares at an average $8.55 ($699,666)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 23,660 shares at $8.56 ($202,541)
- 4 Open-market sale 10% owner sold 127,992 shares at an average $8.59 ($1,099,265)
- 4 Exercise or conversion Chief Accounting Officer acquired 339 shares (option exercise)
- 4 Exercise or conversion Head of Alzheimer's Disease acquired 372 shares (option exercise)
- 4 Open-market sale 10% owner sold 2,604 shares at an average $8.51 ($22,166)
- 4 Open-market sale 10% owner sold 28,884 shares at $8.60 ($248,434)
- 4 Exercise or conversion EVP, Chief Financial Officer acquired 6,005 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 1,275 shares (grant or award)
Page 13 of 86 · 1,714 filings